10/27/2026 | Press release | Archived content
Approximately 90% of pathology labs still rely on glass slides as diagnostic workloads surge 42%, creating diagnosis delays that cost patients time and health systems millions
FDA-cleared, Health Canada licensed, and CE-Marking digital pathology for primary diagnosis, eliminating the last major barrier to clinical adoption at scale
A governed medical imaging architecture that connects pathology to radiology, cardiology, and multi-specialty care teams, without creating another information silo